Molecular functions of metallothionein and its role in hematological malignancies

Journal of Hematology and Oncology

Volumn 5, Issue , 2012, Pages

  Takahashi, Shinichiro ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Hematological malignancies; Metallothionein (MT); Molecular function

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BLEOMYCIN; CISPLATIN; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUKEMIA INHIBITORY FACTOR; MELPHALAN; METALLOTHIONEIN I; METALLOTHIONEIN II; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SCAVENGER;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; CANCER PATIENT; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DISEASE FREE SURVIVAL; DNA DAMAGE; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HUMAN; LARGE CELL LYMPHOMA; LIVER CELL CARCINOMA; MEGAKARYOCYTE; MEGAKARYOCYTE ERYTHROID PROGENITOR; MIXED CELLULARITY HODGKIN LYMPHOMA; NICK END LABELING; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; ZINC METABOLISM;

ANIMALS; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; HEMATOLOGIC NEOPLASMS; HUMANS; METALLOTHIONEIN;

EID: 84864212994     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/1756-8722-5-41     Document Type: Review

References (79)

1. A cadmium protein from equine kidney cortex. M Margoshes, BL Vallee, J Am Chem Soc 1957 79 17 4813 1814 10.1021/ja01574a064
2. Metallothioneins in human tumors and potential roles in carcinogenesis. MG Cherian, A Jayasurya, BH Bay, Mutat Res 2003 533 1-2 201 209 14643421 (Pubitemid 37487869)
3. Metallothionein. DH Hamer, Annu Rev Biochem 1986 55 913 951 10.1146/annurev.bi.55.070186.004405 3527054 (Pubitemid 16070791)
4. Metallothionein and the trace minerals. I Bremner, JH Beattie, Annu Rev Nutr 1990 10 63 83 10.1146/annurev.nu.10.070190.000431 2200476
5. A distinct role for apoptosis in the changes in lymphopoiesis and myelopoiesis created by deficiencies in zinc. PJ Fraker, LE King, FASEB J 2001 15 14 2572 2578 10.1096/fj.01-0430rev 11726532 (Pubitemid 33138128)
6. Metallothionein in physiological and physiopathological processes. P Moffatt, F Denizeau, Drug Metab Rev. 1997 29 1-2 261 307 9187522 (Pubitemid 27293613)
7. Regulation, linkage, and sequence of mouse metallothionein I and II genes. PF Searle, BL Davison, GW Stuart, TM Wilkie, G Norstedt, RD Palmiter, Mol Cell Biol 1984 4 7 1221 1230 6095054 (Pubitemid 16242517)
8. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein. Y Uchida, K Takio, K Titani, Y Ihara, M Tomonaga, Neuron 1991 7 2 337 347 10.1016/0896-6273(91)90272- 2 1873033
9. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. CJ Quaife, SD Findley, JC Erickson, GJ Froelick, EJ Kelly, BP Zambrowicz, et al. Biochemistry 1994 33 23 7250 7259 10.1021/bi00189a029 8003488 (Pubitemid 24208763)
10. Regulation of human metallothionein (MT) genes. Differential expression of MTI-F, MTI-G, and MTII-A genes in the hepatoblastoma cell line (HepG2). C Sadhu, L Gedamu, J Biol Chem 1988 263 6 2679 2684 2830259 (Pubitemid 18062910)
11. Human metallothionein genes-primary structure of the metallothionein-II gene and a related processed gene. M Karin, RI Richards, Nature 1982 299 5886 797 802 10.1038/299797a0 7133118 (Pubitemid 12003298)
12. Structural and functional analysis of the human metallothionein-IA gene: differential induction by metal ions and glucocorticoids. RI Richards, A Heguy, M Karin, Cell 1984 37 1 263 272 10.1016/0092-8674(84)90322-2 6327055 (Pubitemid 14079858)
13. Structure, organization, and regulation of human metallothionein IF gene: differential and cell-type-specific expression in response to heavy metals and glucocorticoids. U Varshney, N Jahroudi, R Foster, L Gedamu, Mol Cell Biol 1986 6 1 26 37 3023827 (Pubitemid 16182080)
14. Cell specificity and an effect of ras on human metallothionein gene expression. CJ Schmidt, DH Hamer, Proc Natl Acad Sci U S A 1986 83 10 3346 3350 10.1073/pnas.83.10.3346 3517857 (Pubitemid 16043033)
15. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. AE Michalska, KH Choo, Proc Natl Acad Sci U S A 1993 90 17 8088 8092 10.1073/pnas.90.17.8088 8367468 (Pubitemid 23260860)
16. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. BA Masters, EJ Kelly, CJ Quaife, RL Brinster, RD Palmiter, Proc Natl Acad Sci U S A 1994 91 2 584 588 10.1073/pnas.91.2.584 8290567 (Pubitemid 24041446)
17. Characterization of metallothionein-I-transgenic mice. MB Iszard, J Liu, Y Liu, T Dalton, GK Andrews, RD Palmiter, et al. Toxicol Appl Pharmacol 1995 133 2 305 312 10.1006/taap.1995.1155 7645027
18. Transgenic mice that overexpress metallothionein-I resist dietary zinc deficiency. T Dalton, K Fu, RD Palmiter, GK Andrews, J Nutr 1996 126 4 825 833 8613884 (Pubitemid 26100951)
19. The role of metallothionein in oncogenesis and cancer prognosis. MO Pedersen, A Larsen, M Stoltenberg, M Penkowa, Prog Histochem Cytochem 2009 44 1 29 64 10.1016/j.proghi.2008.10.001 19348910
20. Metallothionein expression in human neoplasia. SE Theocharis, AP Margeli, JT Klijanienko, GP Kouraklis, Histopathology 2004 45 2 103 118 10.1111/j.1365-2559.2004.01922.x 15279628 (Pubitemid 39120406)
21. Metallothionein: a multifunctional protein from toxicity to cancer. SE Theocharis, AP Margeli, A Koutselinis, Int J Biol Markers. 2003 18 3 162 169 14535585 (Pubitemid 37254280)
22. Differential expression of metallothionein 1 and 2 isoforms in breast cancer lines with different invasive potential: identification of a novel nonsilent metallothionein-1H mutant variant. SK Tai, OJ Tan, VT Chow, R Jin, JL Jones, PH Tan, et al. Am J Pathol 2003 163 5 2009 2019 10.1016/S0002-9440(10) 63559-6 14578200 (Pubitemid 37310031)
23. Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia. GT Tsangaris, J Vamvoukakis, I Politis, AC Kattamis, F Tzortzatou-Stathopoulou, Anticancer Res 2000 20 6B 4407 4411 11205280
24. Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data. A Usvasalo, E Elonen, UM Saarinen-Pihkala, R Raty, A Harila-Saari, P Koistinen, et al. Leuk Res 2010 34 11 1476 1482 10.1016/j.leukres.2010.02.031 20303590
25. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL). A Sauerbrey, F Zintl, J Hermann, M Volm, Anticancer Res 1998 18 2B 1231 1236 9615793 (Pubitemid 28234022)
26. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells. A Imoto, M Okada, T Okazaki, H Kitasato, H Harigae, S Takahashi, J Biol Chem 2010 285 14 10300 10309 10.1074/jbc.M109.095810 20139074
27. Prognostic significance of metallothionein in B-cell lymphomas. CB Poulsen, R Borup, N Borregaard, FC Nielsen, MB Moller, E Ralfkiaer, Blood 2006 108 10 3514 3519 10.1182/blood-2006-04-015305 16868254
28. Expression of metallothionein (MT) and gluthatione s-transferase pi (SGTP) in the bone marrow of patients with myeloproliferative disorders (MPD). T Wrobel, G Mazur, P Dziegiel, P Surowiak, K Kuliczkowski, M Zabel, Folia Morphol (Warsz). 2004 63 1 129 131 (Pubitemid 38325231)
29. Metallothionein as a useful marker in Hodgkin lymphoma subclassification. M Penkowa, BL Sorensen, SL Nielsen, PB Hansen, Leuk Lymphoma. 2009 50 2 200 210 10.1080/10428190802699340 19199157
30. Metallothionein in radiation exposure: its induction and protective role. L Cai, M Satoh, C Tohyama, MG Cherian, Toxicology 1999 132 2-3 85 98 10433372 (Pubitemid 29121947)
31. Oxygen free radicals and metallothionein. M Sato, I Bremner, Free Radic Biol Med 1993 14 3 325 337 10.1016/0891-5849(93)90029-T 8458590 (Pubitemid 23066373)
32. Induction of astrocyte metallothioneins (MTs) by zinc confers resistance against the acute cytotoxic effects of methylmercury on cell swelling, Na+uptake, and K+release. M Aschner, DR Conklin, CP Yao, JW Allen, KH Tan, Brain Res. 1998 813 2 254 261 10.1016/S0006-8993(98)00947-0 9838151 (Pubitemid 29009641)
33. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. L Cai, J Koropatnick, MG Cherian, Chem Biol Interact. 1995 96 2 143 155 10.1016/0009-2797(94)03585-V 7728904
34. Enhanced apoptosis in metallothionein null cells. Y Kondo, JM Rusnak, DG Hoyt, CE Settineri, BR Pitt, JS Lazo, Mol Pharmacol 1997 52 2 195 201 9271341 (Pubitemid 27349610)
35. Downregulated expression of metallothionein and its clinicopathological significance in hepatocellular carcinoma. X Tao, JM Zheng, AM Xu, XF Chen, SH Zhang, Hepatol Res 2007 37 10 820 827 10.1111/j.1872-034X.2007.00113.x 17517078 (Pubitemid 47308224)
36. Cell cycle regulation of metallothionein in human colonic cancer cells. WW Nagel, BL Vallee, Proc Natl Acad Sci U S A 1995 92 2 579 583 10.1073/pnas.92.2.579 7831333
37. Localization of metallothionein in nuclei of growing primary cultured adult rat hepatocytes. K Tsujikawa, T Imai, M Kakutani, Y Kayamori, T Mimura, N Otaki, et al. FEBS Lett 1991 283 2 239 242 10.1016/0014-5793(91)80597-V 2044762
38. Influence of metallothionein-1 localization on its function. M Levadoux-Martin, JE Hesketh, JH Beattie, HM Wallace, Biochem J 2001 355 Pt 2 473 479 11284736 (Pubitemid 32397808)
39. Metallothionein accretion in human hepatic cells is linked to cellular proliferation. R Studer, CP Vogt, M Cavigelli, PE Hunziker, JH Kagi, Biochem J 1997 328 Pt 1 63 67 9359834 (Pubitemid 27499440)
40. Role of metallothionein in carcinogenesis. MG Cherian, SB Howell, N Imura, CD Klaassen, J Koropatnick, JS Lazo, et al. Toxicol Appl Pharmacol 1994 126 1 1 5 10.1006/taap.1994.1083 8184419 (Pubitemid 24168861)
41. Reversible zinc exchange between metallothionein and the estrogen receptor zinc finger. DF Cano-Gauci, B Sarkar, FEBS Lett 1996 386 1 1 4 10.1016/0014-5793(96)00356-0 8635592 (Pubitemid 26143789)
42. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. W Maret, C Jacob, BL Vallee, EH Fischer, Proc Natl Acad Sci U S A 1999 96 5 1936 1940 10.1073/pnas.96.5.1936 10051573 (Pubitemid 29117846)
43. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. C Meplan, MJ Richard, P Hainaut, Oncogene 2000 19 46 5227 5236 10.1038/sj.onc.1203907 11077439
44. Metal ions as regulators of the conformation and function of the tumour suppressor protein p53: implications for carcinogenesis. C Meplan, G Verhaegh, MJ Richard, P Hainaut, Proc Nutr Soc 1999 58 3 565 571 10.1017/S0029665199000749 10604188
45. Nucleophilic distribution of metallothionein in human tumor cells. ES Woo, Y Kondo, SC Watkins, DG Hoyt, JS Lazo, Exp Cell Res. 1996 224 2 365 371 10.1006/excr.1996.0146 8612713 (Pubitemid 26140570)
46. Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. J Zeng, R Heuchel, W Schaffner, JH Kagi, FEBS Lett 1991 279 2 310 312 10.1016/0014-5793(91)80175-3 2001744
47. Zinc transfer from transcription factor IIIA fingers to thionein clusters. J Zeng, BL Vallee, JH Kagi, Proc Natl Acad Sci U S A 1991 88 22 9984 9988 10.1073/pnas.88.22.9984 1835092 (Pubitemid 21915759)
48. Role of metallothionein as a protective factor against radiation carcinogenesis. K Shibuya, N Nishimura, JS Suzuki, C Tohyama, A Naganuma, M Satoh, J Toxicol Sci 2008 33 5 651 655 10.2131/jts.33.651 19043287
49. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. JS Lazo, SM Kuo, ES Woo, BR Pitt, Chem Biol Interact. 1998 111-112 255 262 21621526 (Pubitemid 28271949)
50. DNA radiation damage and its modification by metallothionein. CL Greenstock, CP Jinot, RP Whitehouse, MD Sargent, Free Radic Res Commun 1987 2 4-6 233 239 3504809
51. Cadmium induces apoptosis in a human T cell line. B el Azzouzi, GT Tsangaris, O Pellegrini, Y Manuel, J Benveniste, Y Thomas, Toxicology 1994 88 1-3 127 139 8160194
52. Cadmium-induced oxidative cellular damage in human fetal lung fibroblasts (MRC-5 cells). CF Yang, HM Shen, Y Shen, ZX Zhuang, CN Ong, Environ Health Perspect. 1997 105 7 712 716 10.1289/ehp.97105712 9294717 (Pubitemid 27450331)
53. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. AB Abdel-Mageed, KC Agrawal, Cancer Res 1998 58 11 2335 2338 9622069 (Pubitemid 28252689)
54. Regulatory role of metallothionein in NF-kappaB activation. A Sakurai, S Hara, N Okano, Y Kondo, J Inoue, N Imura, FEBS Lett 1999 455 1-2 55 58 10428471 (Pubitemid 29322781)
55. Metallothionein is a potential negative regulator of apoptosis. R Shimoda, WE Achanzar, W Qu, T Nagamine, H Takagi, M Mori, et al. Toxicol Sci 2003 73 2 294 300 10.1093/toxsci/kfg095 12700406 (Pubitemid 36701735)
56. Metallothionein null cells have increased sensitivity to anticancer drugs. Y Kondo, ES Woo, AE Michalska, KH Choo, JS Lazo, Cancer Res 1995 55 10 2021 2023 7743495
57. Metallothionein and apoptosis in primary human hepatocellular carcinoma (HCC) from northern China. L Cai, GJ Wang, ZL Xu, DX Deng, S Chakrabarti, MG Cherian, Anticancer Res 1998 18 6B 4667 4672 9891538 (Pubitemid 29042041)
58. Metallothionein and apoptosis in primary human hepatocellular carcinoma and metastatic adenocarcinoma. DX Deng, S Chakrabarti, MP Waalkes, MG Cherian, Histopathology 1998 32 4 340 347 10.1046/j.1365-2559.1998.00348.x 9602331 (Pubitemid 28186593)
59. Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation. JL Chin, D Banerjee, SA Kadhim, TE Kontozoglou, PJ Chauvin, MG Cherian, Cancer 1993 72 10 3029 3035 10.1002/1097-0142(19931115)72: 10<3029::AID-CNCR2820721027>3.0.CO;2-6 8221570 (Pubitemid 23335051)
60. Prognostic significance of metallothionein expression in correlation with Ki-67 expression in adenocarcinomas of large intestine. P Dziegiel, J Forgacz, E Suder, P Surowiak, J Kornafel, M Zabel, Histol Histopathol 2003 18 2 401 407 12647790 (Pubitemid 36362057)
61. Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. I Germain, B Tetu, J Brisson, M Mondor, MG Cherian, Int J Gynecol Pathol 1996 15 1 54 62 10.1097/00004347-199601000-00009 8852447 (Pubitemid 26009671)
62. Prognostic evaluation of metallothionein expression in human colorectal neoplasms. EE Ioachim, AC Goussia, NJ Agnantis, M Machera, EV Tsianos, AM Kappas, J Clin Pathol 1999 52 12 876 879 10.1136/jcp.52.12.876 10711249 (Pubitemid 30005359)
63. A p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. D Duval, M Malaise, B Reinhardt, C Kedinger, H Boeuf, Cell Death Differ. 2004 11 3 331 341 10.1038/sj.cdd.4401337 14685156 (Pubitemid 38313142)
64. Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells. D Duval, M Trouillas, C Thibault, D Dembele, F Diemunsch, B Reinhardt, et al. Cell Death Differ. 2006 13 4 564 575 10.1038/sj.cdd.4401789 16311515
65. Differential quantitative zinc-induced expression of human metallothionein isogenes in haematopoietic precursor cell lines. P Maghdooni Bagheri, MT Rahman, S Van Soest, M De Ley, J Trace Elem Med Biol 2009 23 2 124 131 10.1016/j.jtemb.2009.02.003 19398060
66. Induced differentiation of K562 leukemia cells: a model for studies of gene expression in early megakaryoblasts. R Alitalo, Leuk Res 1990 14 6 501 514 10.1016/0145-2126(90)90002-Q 2197510 (Pubitemid 20213713)
67. Metallothionein in human immunomagnetically selected CD34(+) haematopoietic progenitor cells. P Maghdooni Bagheri, M De Ley, Cell Biol Int 2011 35 1 39 44 10.1042/CBI20090493 20828370
68. Role of metallothionein in differentiation of leukemia cells. P Maghdooni Bagheri, I Govaerts, M De Ley, Mol Biol Rep 2011 38 5 3017 3022 10.1007/s11033-010-9967-7 20127519
69. Zinc metabolism and metallothionein expression in bone marrow during erythropoiesis. KL Huber, RJ Cousins, Am J Physiol 1993 264 5 Pt 1 770 E775 8498498
70. Erythropoietin-induced metallothionein gene expression: role in proliferation of K562 cells. AB Abdel-Mageed, F Zhao, BJ Rider, KC Agrawal, Exp Biol Med (Maywood). 2003 228 9 1033 1039 (Pubitemid 37222172)
71. Metallothionein expression prevents apoptosis: a study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line. GT Tsangaris, F Tzortzatou-Stathopoulou, Anticancer Res 1998 18 4A 2423 2433 9703889 (Pubitemid 28386530)
72. Current findings for recurring mutations in acute myeloid leukemia. S Takahashi, J Hematol Oncol. 2011 4 36 10.1186/1756-8722-4-36 21917154
73. Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. A Sauerbrey, F Zintl, M Volm, Ann Hematol 1994 69 3 111 115 10.1007/BF01695690 8086505 (Pubitemid 24284966)
74. Inverse correlation between Flt3 and PU.1 expression in acute myeloblastic leukemias. M Inomata, S Takahashi, H Harigae, J Kameoka, M Kaku, T Sasaki, Leuk Res 2006 30 6 659 664 10.1016/j.leukres.2005.07.015 16271760
75. Biologic and clinical significance of the FLT3 transcript level in acute myeloid leukemia. K Ozeki, H Kiyoi, Y Hirose, M Iwai, M Ninomiya, Y Kodera, et al. Blood 2004 103 5 1901 1908 10.1182/blood-2003-06-1845 14604973 (Pubitemid 38268989)
76. Detailed analysis of FLT3 expression levels in acute myeloid leukemia. F Kuchenbauer, W Kern, C Schoch, A Kohlmann, W Hiddemann, T Haferlach, et al. Haematologica 2005 90 12 1617 1625 16330434 (Pubitemid 41814985)
77. Prognostic significance of PU.1 in follicular lymphoma. EE Torlakovic, N Bilalovic, R Golouh, A Zidar, S Angel, J Pathol 2006 209 3 352 359 10.1002/path.1986 16639693 (Pubitemid 43997744)
78. Metallothionein: a potential marker for differentiating benign and neoplastic gastrointestinal lymphoid infiltrates. KS Rizkalla, MG Cherian, Pathology 1997 29 2 141 146 10.1080/00313029700169764 9213332 (Pubitemid 27296460)
79. Pathobiology of classical Hodgkin lymphoma. A Tzankov, S Dirnhofer, Pathobiology 2006 73 3 107 125 10.1159/000095558 17085956 (Pubitemid 44699471)